SMS Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SMS Pharmaceuticals Limited generated cash of $501,247,000, which is more than the previous year. Cash used in financing activities reached the amount of $306,790,000 last year. Net change in cash is therefore $287,317,000.
Cash Flow
| 2010 | 252.45M | -582.22M | 178.50M |
|---|---|---|---|
| 2011 | 145.93M | -255.61M | 116.98M |
| 2012 | 198.15M | -245.43M | 77.62M |
| 2016 | 612.19M | -967.15M | 266.52M |
| 2018 | 318.14M | -165.77M | -148.92M |
| 2020 | 397.11M | -425.63M | -24.01M |
| 2021 | 904.53M | -1.51B | 920.17M |
| 2023 | 224.5M | -296.86M | -319.68M |
| 2024 | 501.24M | -520.72M | 306.79M |
SMSPHARMA.NS Cash Flow Statement (2010 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 73.07M | 465.82M | 95.44M | 147.97M | 122.85M | 24.07M | 59.78M | 52.48M | 203.74M |
Operating activities | |||||||||
Net income | 498.26M | 53.49M | 911.19M | 507.55M | 603.48M | 562.72M | 11.37M | 83.92M | 23.95M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 315.15M | 321.25M | 222.81M | 220.66M | 198.99M | 194.33M | 126.39M | 126.42M | 83.64M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -878.47M | -998.26M | -569.87M | -227.48M | -28.63M | -24.45M | 0 | 0 | 0 |
Inventories | -101.98M | 275.98M | -85.87M | 71.99M | -149.56M | -266.63M | -236.60M | -386.50M | -38.43M |
Accounts payable | 438.67M | 402.90M | 209.46M | -37.57M | -280.49M | 239.46M | 0 | 0 | 0 |
Cash generated by operating activities | 501.24M | 224.5M | 904.53M | 397.11M | 318.14M | 612.19M | 198.15M | 145.93M | 252.45M |
Investing activities | |||||||||
Purchases Of Investments | 0 | -980K | -1.66M | -2.74M | -80.25M | -80.40M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -521.6M | -299.20M | -1.51B | -427.34M | -85.53M | -887.86M | -229.79M | -18.91M | -1.37B |
Acquisitions Net | 0 | 2.63M | 1.33M | 1.33M | 0 | 1.12M | 0 | 0 | 0 |
Cash generated by investing activities | -520.72M | -296.86M | -1.51B | -425.63M | -165.77M | -967.15M | -245.43M | -255.61M | -582.22M |
Financing activities | |||||||||
Common Stock Issued | 284.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -25.39M | -25.39M | 0 | -51.02M | -20.37M | -20.37M | -17.46M | -23.40M | -23.40M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 275.29M | -343.78M | -192.92M | 84.59M | -30.21M | 370.27M | -218.84M | -181.09M | -317.20M |
Cash used in financing activities | 306.79M | -319.68M | 920.17M | -24.01M | -148.92M | 266.52M | 77.62M | 116.98M | 178.50M |
Net Change In Cash | 287.31M | -392.05M | 308.78M | -52.53M | 3.45M | 88.43M | 30.35M | 7.29M | -151.25M |
Cash at end of period | 360.39M | 73.77M | 404.23M | 95.44M | 126.30M | 112.51M | 90.14M | 59.78M | 52.48M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |